EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomy

Diederik J H Baas, Bas Israël, Joost M S de Baaij, Henricus J E J Vrijhof, Robert J Hoekstra, Heidi Kusters-Vandevelde, Peter F A Mulders, J P Michiel Sedelaar, Diederik M Somford, Jean-Paul A van Basten

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05321-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Diederik J H Baas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, Nijmegen, 6532 SZ, The Netherlands. d.baas@cwz.nl. Hauptthemen laut MEDLINE: Prostatectomy, Lymph Node Excision, Prostatic Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the effectiveness of extended (e-PLND) and super-extended pelvic lymph node dissection (se-PLND) during robot-assisted radical prostatectomy (RARP) by examining lymph node (LN) yield, complications, LN metastasis, and biochemical recurrence (BCR) incidence.

Methods

Between January 2016 and January 2020, 354 consecutive patients with > 5% risk of lymph node involvement (LNI), as predicted by the Memorial Sloan Kettering Cancer Center nomogram, underwent RARP with (s)e-PLND at a high-volume center. The e-PLND involved removing fibrofatty lymphatic tissue around the obturator fossa, internal iliac region, and external iliac vessels. The se-PLND, performed at the discretion of the surgeons, also included lymph nodes from the pre-sacral and common iliac regions. Outcomes included histopathological findings by anatomical region; complications; and BCR incidence during follow-up.

Results

The median LNI risk was 18% (IQR 9–31%). A median of 22 LN (IQR 16–28) were removed, with se-PLND yielding a higher number: 25 (IQR 20–32) compared to e-PLND: 17 (IQR 13–24) ( p < 0.001). pN1 disease was detected in 22% of patients overall, higher in se-PLND (29%) than e-PLND (14%) ( p < 0.001). Of metastatic LNs, 14% were situated outside the e-PLND template. Operation time was longer for se-PLND, but perioperative complications were similar between both groups. After a median follow-up of 24 months (IQR 7–33), BCR incidence was comparable between the two groups.

Conclusion

Compared to standard extended pelvic lymph node dissection (PLND), super extended PLND increases lymph node yield and removal of metastatic deposits but does not contribute to progression free survival at mid-term.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyLymph Node ExcisionProstatic NeoplasmsNeoplasm Recurrence, LocalPostoperative ComplicationsHumansMaleMiddle AgedAgedRetrospective StudiesLymphatic MetastasisRobotic Surgical ProceduresProstate-Specific AntigenPelvis

Stichwörter der Autor:innen

Biochemical recurrenceComplicationsOncological outcomesPelvic lymph node dissection (PLND)Prostate cancerProstatectomy

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, Nijmegen, 6532 SZ, The Netherlands. d.baas@cwz.nl.
  • Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. d.baas@cwz.nl.
  • Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands. d.baas@cwz.nl.
  • Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Urology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, Nijmegen, 6532 SZ, The Netherlands.
  • Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands.

Zitieren

APA

Baas, D. J. H., Israël, B., de Baaij, J. M. S., Vrijhof, H. J. E. J., Hoekstra, R. J., Kusters-Vandevelde, H., Mulders, P. F. A., Michiel Sedelaar, J. P., Somford, D. M., & van Basten, J. A. (2024). Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomy. World Journal of Urology. https://doi.org/10.1007/s00345-024-05321-6

Vancouver

Baas DJH, Israël B, de Baaij JMS, Vrijhof HJEJ, Hoekstra RJ, Kusters-Vandevelde H, et al. Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomy. World Journal of Urology. 2024. doi:10.1007/s00345-024-05321-6

BibTeX
@article{Baas2024,
  author = {Baas, Diederik J H and Israël, Bas and de Baaij, Joost M S and Vrijhof, Henricus J E J and Hoekstra, Robert J and Kusters-Vandevelde, Heidi and Mulders, Peter F A and Michiel Sedelaar, J P and Somford, Diederik M and van Basten, Jean-Paul A},
  title = {Evaluation of complications and biochemical recurrence rates after (super) extended lymph node dissection during radical prostatectomy},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05321-6}
}
Kostenlos starten →